Dataset Information


EEG power spectra response to a 4-h phase advance and gaboxadol treatment in 822 men and women.

ABSTRACT: To explore the effect of gaboxadol on NREM EEG in transient insomnia using power spectral analysis and evaluate the response between men and women.This was a randomized, double-blind, 3-way, parallel-group transient insomnia study in 22 sleep laboratories. After a baseline night (N1), subjects underwent a 4-h phase-advance of their habitual sleep time the following night (N2). Healthy subjects aged 18-64 y were given single-blind placebo on N1 followed by double-blind treatment on N2 (gaboxadol 10 mg [n = 271], 15 mg [n = 274], or placebo [n = 277])At baseline, women showed significantly greater values in low frequency activity (< 10 Hz) and in high spindle/low beta frequency activity (14-18 Hz) compared to men. During the phase advance (placebo N2-baseline N1), there was a significant increase in power within the high spindle/low beta frequency range (15-17 Hz) and a significant reduction in beta activity (20-32 Hz), which was greater in women than men. Gaboxadol induced a significant (dose-related) increase in low frequencies (< 8 Hz) and a significant (dose-related) decrease within the alpha/spindle range (11-12 Hz). The effect was dependent upon sex, with a greater magnitude of effect observed in women than men.Gaboxadol shows a characteristic NREM EEG spectral profile in a model of transient insomnia. Men and women show clear differences in NREM EEG activity at baseline, to gaboxadol treatment and to phase-shifts in habitual sleep/wake times. The exact mechanisms underlying the sex differences remain unclear, but sex is an important variable in studies evaluating sleep and gaboxadol. TRIAL REGISTRY INFORMATION:www.clinicaltrials.gov, study identifier: NCT00102167.


PROVIDER: S-EPMC3190849 | BioStudies | 2011-01-01

REPOSITORIES: biostudies

Similar Datasets

| S-EPMC6328336 | BioStudies
1000-01-01 | S-EPMC4791614 | BioStudies
| S-EPMC6865651 | BioStudies
2016-01-01 | S-EPMC4835300 | BioStudies
| S-EPMC4322643 | BioStudies
1000-01-01 | S-EPMC4909625 | BioStudies
| S-EPMC6570568 | BioStudies
2020-01-01 | S-EPMC7522718 | BioStudies
| S-EPMC6869089 | BioStudies
| S-EPMC6390176 | BioStudies